NASH and Nutritional Therapy
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Tokyo :
Springer Tokyo,
2005.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Nonalcoholic Fatty Liver (NAFL): Overview
- Role of Leptin in Pathogenesis of NASH
- Zone 3 Predominance of Histopathological Features in Nonalcoholic Steatohepatitis
- Genetic Background of Japanese Patients with Nonalcoholic Steatohepatitis (NASH)
- Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH
- Clinical Features of Patients with Nonalcoholic Fatty Liver Disease
- Pathogenesis and Significance of Restricted Diet and Exercise Therapy in Nonalcoholic Steatohepatitis (NASH)
- Mammalian Target of Rapamycin (mTOR)
- Effect of Oral Supplementation with Branched-Chain Amino Acids on Albumin Concentration in the Early Stage of Cirrhosis
- Nutritional Therapy in Patients with Liver Cirrhosis.